跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUFENTANIL CITRATE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUFENTANIL CITRATE INJECTION USP
Authorized
STANDARD
SUFENTANIL CITRATE INJECTION USP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
083d6cb5042231b3
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
083d6cb5042231b3
Drug Approval Canada Name
SUFENTANIL CITRATE INJECTION USP
Product Name
SUFENTANIL CITRATE INJECTION USP
Status
Marketed
Status Date
2019-05-27
Original Market Date
2016-10-18
Din
02442213
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Epidural
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N01AH03 SUFENTANIL
Atc Name
n 01 ah 03
Aig Number
0144821002
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
SUFENTANIL (SUFENTANIL CITRATE)
50 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
083d6cb5042231b3
Type
Standard
Back to Health Canada Approvals